Novartis could have a U.S. deal that shields it from tariffs, CEO tells CNBC

CNBC Published Updated Stocks
Sign in to save

Why it matters

Novartis CEO suggests the company may have a deal in place to shield itself from US tariffs, potentially mitigating the impact of Trump's latest trade measures on the European pharma sector.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Neutral Confidence 70% How confidence is read Horizon: Short term Impact: Moderate

Market impact analysis based on neutral sentiment with 70% confidence.

Evidence trail

Evidence
Source CNBC
Claim Novartis could have a U.S. deal that shields it from tariffs, CEO tells CNBC
AI inference Neutral · 70%
Generated 2026-01-20 10:14

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
34589

Original source

The continent's pharma sector could be one of its worst hit by Trump's latest tariffs on some European countries.

Read the full article on CNBC

Original article published by CNBC on January 20, 2026. Analysis and insights provided by AnalystMarkets AI.

Related coverage